BioSpace News Archive

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, and Oxurion today announced full enrollment of Oxurion’s Phase I trial designed to evaluate the safety of a single injection of THR-149, a novel Bicycle-based plasma kallikrein (PKal) inhibitor.

Brunel International and Specialisterne Foundation established a partnership to collaborate on the inclusion of autistic and neurodiverse people in the global labour market.

New report from Amsety’s Liver Health Score offers powerful insight into what drives the rapid rise of liver disease in the U.S.

The wearable product provides incredible relief from back pain as well as helping to improve performance in your favorite activities such as golf and tennis.

New 150kV superficial treatment system and SARRP research platform among advanced solutions showcased on Xstrahl booth at European Society for Radiotherapy & Oncology annual meeting in Milan, April 26th-29th

Hempure, a CBD supplement company, has launched Dr. Hemphry – an interactive chat bot that answers all your CBD and hemp related questions.

Free Event Opens to Public on May 4 to Generate Excitement about Math

Nova Medical Centers, one of the nation’s top occupational medicine providers, is introducing its free Physician Tele-Triage service.

“The Optimal Solution” is a team of seasoned industry innovators cooperatively leveraging their expertise to demonstrate interoperability at scale in the pharma supply chain ecosystem. Team members include: RXTransparent, Systech, T-Systems, FarmaTrust, Cryptowerk and CalQLogic.

Funding supports Phase 3 development of STS101 for the acute treatment of migraine, including pivotal Phase 3 efficacy trial with planned initiation in Q3 2019